Beta-lactam and Beta-lactamase Inhibitors: Market Outlook 2025-2033
the innovative development of advanced combination therapies that pair beta-lactam antibiotics with enzyme inhibitors, and ongoing breakthroughs in pharmaceuticals. In this highly competitive landscape, major players like Pfizer, Merck, GSK, Novartis, and Abbott are leading the charge across key drug segments